95TiP DUART: A phase II study of durvalumab following radiotherapy in patients with unresectable, stage III NSCLC ineligible for chemotherapy

التفاصيل البيبلوغرافية
العنوان: 95TiP DUART: A phase II study of durvalumab following radiotherapy in patients with unresectable, stage III NSCLC ineligible for chemotherapy
المؤلفون: Andrea Riccardo Filippi, M.R. Garcia Campelo, J-B. Paoli, I. Diaz Perez, W. Sawyer, Rafal Dziadziuszko
المصدر: Journal of Thoracic Oncology. 16:S747
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Chemotherapy, Durvalumab, business.industry, medicine.medical_treatment, Stage III NSCLC, Phases of clinical research, Radiation therapy, Internal medicine, Medicine, In patient, business
تدمد: 1556-0864
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5b14799d31717beab529ba7bcfc11187
https://doi.org/10.1016/s1556-0864(21)01937-7
حقوق: OPEN
رقم الأكسشن: edsair.doi...........5b14799d31717beab529ba7bcfc11187
قاعدة البيانات: OpenAIRE